{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:13:50Z","timestamp":1790856830887,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:00:00Z","timestamp":1732147200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:00:00Z","timestamp":1732147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006469","name":"Macao Science and Technology Development Fund","doi-asserted-by":"crossref","award":["002\/2023\/ALC"],"award-info":[{"award-number":["002\/2023\/ALC"]}],"id":[{"id":"10.13039\/501100006469","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Guangdong-Hong Kong-Macao Universities Joint Laboratory for the Internationalization of Traditional Chinese Medicine","award":["2023LSYS002"],"award-info":[{"award-number":["2023LSYS002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biomark Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Activating the ubiquitin-proteasome system to dismantle disease- related proteins such as tau, \u03b2-amyloid, APP, and \u03b1-synuclein is an important focus in the research of neurodegenerative proteinopathy. By analyzing the serum RNA extracted from wild-type and Alzheimer\u2019s disease (AD) transgenic mice at different ages (4, 8, and 12 months), this study revealed a new protective role of FBXL16 in AD, primarily through facilitating the degradation of disease-related proteins via the ubiquitin proteasome system.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Proteomic analysis were conducted using protein lysates from HEK293 cells overexpressing FBXL16 to identify potential interacting proteins that interact with FBXL16. Subsequent experiments demonstrated that FBXL16 promotes the proteasomal degradation of the APP protein, as evidenced by co-immunoprecipitation with MG132 and cycloheximide (CHX), immunohistochemistry (IHC) and immunocytochemistry (ICC). Memory and cognitive improvements were observed in 3\u00d7Tg AD mice through the use of a lentivirus-mediated approach to generate a brain-specific AD mouse model overexpressing FBXL16 via stereotaxic injection. Furthermore, a brain-specific conditional knockout (cko) FBXL16 mouse model was generated and employed to further confirm the functional role of FBXL 16 in AD via various behavioral tests including Morris water maze and Y-maze.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The level of FBXL16 in the brains of transgenic APP\/PSEN mice with AD decreased with age. Accelerated degradation of APP was observed when FBXL16 was overexpressed in the hippocampi of these AD mice via a lentivirus. This process led to notable improvements in cognitive impairments and reductions in neuroinflammation. Further studies using proteomics and bioinformatics techniques identified transcription factors and binding proteins associated with FBXL16, providing deeper insights into the potential role of FBXL16 in the regulation of AD. Finally, the in vivo effects of FBXL16 deficiency were further substantiated in cko mice, which overexpress A\u03b2 but specifically lack FBXL16 in the brain region.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>These findings suggest that FBXL16 could be a new regulator of AD. These findings provide a foundation for further research into drug development and potential therapeutic strategies to combat other related neurodegenerative proteinopathies.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40364-024-00691-w","type":"journal-article","created":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T23:43:52Z","timestamp":1732146232000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["FBXL16: a new regulator of neuroinflammation and cognition in Alzheimer\u2019s disease through the ubiquitination-dependent degradation of amyloid precursor protein"],"prefix":"10.1186","volume":"12","author":[{"given":"Liqun","family":"Qu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyun","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang Hong","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingxia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruilong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menghan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cairen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome P. L.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianjun","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Io Nam","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent Kam Wai","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betty Yuen Kwan","family":"Law","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,21]]},"reference":[{"issue":"3","key":"691_CR1","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","volume":"7","author":"MS Albert","year":"2011","unstructured":"Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7(3):270\u20139.","journal-title":"Alzheimers Dement"},{"issue":"11","key":"691_CR2","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.tics.2011.09.004","volume":"15","author":"WJ Jagust","year":"2011","unstructured":"Jagust WJ, Mormino EC. Lifespan brain activity, beta-amyloid, and Alzheimer\u2019s disease. Trends Cogn Sci. 2011;15(11):520\u20136.","journal-title":"Trends Cogn Sci"},{"key":"691_CR3","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.brainres.2017.10.012","volume":"1678","author":"J Tai","year":"2018","unstructured":"Tai J, Liu W, Li Y, Li L, Holscher C. Neuroprotective effects of a triple GLP-1\/GIP\/glucagon receptor agonist in the APP\/PS1 transgenic mouse model of Alzheimer\u2019s disease. Brain Res. 2018;1678:64\u201374.","journal-title":"Brain Res"},{"issue":"4","key":"691_CR4","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.3233\/JAD-161118","volume":"57","author":"R Kandimalla","year":"2017","unstructured":"Kandimalla R, Reddy PH. Therapeutics of neurotransmitters in Alzheimer\u2019s disease. J Alzheimers Dis. 2017;57(4):1049\u201369.","journal-title":"J Alzheimers Dis"},{"issue":"5:101547","key":"691_CR5","first-page":"1","volume":"69","author":"MDM Marsool","year":"2023","unstructured":"Marsool MDM, Prajjwal P, Reddy YB, Marsool ADM, Lam JR, Nandwana V. Newer modalities in the management of Alzheimer\u2019s dementia along with the role of aducanumab and lecanemab in the treatment of its refractory cases. Dis Mon. 2023;69(5:101547):1\u201319.","journal-title":"Dis Mon"},{"issue":"1","key":"691_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/nrd3321","volume":"10","author":"L Bedford","year":"2011","unstructured":"Bedford L, Lowe J, Dick LR, Mayer RJ, Brownell JE. Ubiquitin-like protein conjugation and the ubiquitin-proteasome system as drug targets. Nat Rev Drug Discov. 2011;10(1):29\u201346.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"691_CR7","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.nbd.2006.02.004","volume":"23","author":"L Chen","year":"2006","unstructured":"Chen L, Thiruchelvam MJ, Madura K, Richfield EK. Proteasome dysfunction in aged human alpha-synuclein transgenic mice. Neurobiol Dis. 2006;23(1):120\u20136.","journal-title":"Neurobiol Dis"},{"issue":"1:117","key":"691_CR8","first-page":"1","volume":"23","author":"J Nowakowska-Golacka","year":"2021","unstructured":"Nowakowska-Golacka J, Czapiewska J, Sominka H, Sowa-Rogozinska N, Slominska-Wojewodzka M. EDEM1 regulates amyloid precursor protein (APP) metabolism and amyloid-beta production. Int J Mol Sci. 2021;23(1:117):1\u201322.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"691_CR9","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1038\/sj.cdd.4402180","volume":"14","author":"Z Tan","year":"2007","unstructured":"Tan Z, Sun X, Hou FS, Oh HW, Hilgenberg LG, Hol EM, et al. Mutant ubiquitin found in Alzheimer\u2019s disease causes neuritic beading of mitochondria in association with neuronal degeneration. Cell Death Differ. 2007;14(10):1721\u201332.","journal-title":"Cell Death Differ"},{"key":"691_CR10","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/B978-0-12-804766-8.00013-3","volume":"167","author":"JA Soria Lopez","year":"2019","unstructured":"Soria Lopez JA, Gonzalez HM, Leger GC. Alzheimer\u2019s disease. Handb Clin Neurol. 2019;167:231\u201355.","journal-title":"Handb Clin Neurol"},{"issue":"2","key":"691_CR11","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S0896-6273(03)00606-8","volume":"40","author":"A Ciechanover","year":"2003","unstructured":"Ciechanover A, Brundin P. The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg. Neuron. 2003;40(2):427\u201346.","journal-title":"Neuron"},{"issue":"23","key":"691_CR12","doi-asserted-by":"publisher","first-page":"7970","DOI":"10.1074\/jbc.RA120.012658","volume":"295","author":"M Morel","year":"2020","unstructured":"Morel M, Shah KN, Long W. The F-box protein FBXL16 up-regulates the stability of C-MYC oncoprotein by antagonizing the activity of the F-box protein FBW7. J Biol Chem. 2020;295(23):7970\u201380.","journal-title":"J Biol Chem"},{"issue":"7621","key":"691_CR13","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/nature19356","volume":"537","author":"ME Dickinson","year":"2016","unstructured":"Dickinson ME, Flenniken AM, Ji X, Teboul L, Wong MD, White JK, et al. High-throughput discovery of novel developmental phenotypes. Nature. 2016;537(7621):508\u201314.","journal-title":"Nature"},{"issue":"3","key":"691_CR14","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1074\/mcp.M113.031765","volume":"13","author":"N Honarpour","year":"2014","unstructured":"Honarpour N, Rose CM, Brumbaugh J, Anderson J, Graham RLJ, Sweredoski MJ, et al. F-box protein FBXL16 binds PP2A-B55 and regulates differentiation of embryonic stem cells along the FLK1 lineage. Mol Cell Proteom. 2014;13(3):780\u201391.","journal-title":"Mol Cell Proteom"},{"key":"691_CR15","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.biocel.2016.02.005","volume":"73","author":"N Zheng","year":"2016","unstructured":"Zheng N, Wang Z, Wei W. Ubiquitination-mediated degradation of cell cycle-related proteins by F-box proteins. Int J Biochem Cell Biol. 2016;73:99\u2013110.","journal-title":"Int J Biochem Cell Biol"},{"issue":"4","key":"691_CR16","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s11357-016-9929-7","volume":"38","author":"H Huang","year":"2016","unstructured":"Huang H, Nie S, Cao M, Marshall C, Gao J, Xiao N, et al. Characterization of AD-like phenotype in aged APPSwe\/PS1dE9 mice. Age (Dordr). 2016;38(4):303\u201322.","journal-title":"Age (Dordr)"},{"issue":"3","key":"691_CR17","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41588-018-0311-9","volume":"51","author":"IE Jansen","year":"2019","unstructured":"Jansen IE, Savage JE, Watanabe K, Bryois J, Williams DM, Steinberg S, et al. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer\u2019s disease risk. Nat Genet. 2019;51(3):404\u201313.","journal-title":"Nat Genet"},{"issue":"2","key":"691_CR18","first-page":"479","volume":"36","author":"K Sato","year":"2010","unstructured":"Sato K, Kusama Y, Tategu M, Yoshida K. FBXL16 is a novel E2F1-regulated gene commonly upregulated in p16INK4A- and p14ARF-silenced HeLa cells. Int J Oncol. 2010;36(2):479\u201390.","journal-title":"Int J Oncol"},{"issue":"10","key":"691_CR19","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1038\/nn.3509","volume":"16","author":"DA Crowe","year":"2013","unstructured":"Crowe DA, Goodwin SJ, Blackman RK, Sakellaridi S, Sponheim SR, MacDonald AW 3, et al. Prefrontal neurons transmit signals to parietal neurons that reflect executive control of cognition. Nat Neurosci. 2013;16(10):1484\u201391.","journal-title":"Nat Neurosci"},{"issue":"5\u20136","key":"691_CR20","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.lfs.2011.05.011","volume":"89","author":"W Liu","year":"2011","unstructured":"Liu W, Tang Y, Feng J. Cross talk between activation of microglia and astrocytes in pathological conditions in the central nervous system. Life Sci. 2011;89(5\u20136):141\u20136.","journal-title":"Life Sci"},{"issue":"30","key":"691_CR21","first-page":"2","volume":"7","author":"H Wilms","year":"2010","unstructured":"Wilms H, Sievers J, Rickert U, Rostami-Yazdi M, Mrowietz U, Lucius R. Dimethylfumarate inhibits microglial and astrocytic inflammation by suppressing the synthesis of nitric oxide, IL-1beta, TNF-alpha and IL-6 in an in-vitro model of brain inflammation. J Neuroinflammation. 2010;7(30):2\u20138.","journal-title":"J Neuroinflammation"},{"issue":"11","key":"691_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms23115954","volume":"23","author":"RI Teleanu","year":"2022","unstructured":"Teleanu RI, Niculescu AG, Roza E, Vladacenco O, Grumezescu AM, Teleanu DM. Neurotransmitters-key factors in neurological and neurodegenerative disorders of the central nervous system. Int J Mol Sci. 2022;23(11):1\u201324.","journal-title":"Int J Mol Sci"},{"issue":":1270","key":"691_CR23","first-page":"1","volume":"11","author":"YK Kim","year":"2020","unstructured":"Kim YK, Kim OY, Song J. Alleviation of depression by glucagon-like peptide 1 through the regulation of neuroinflammation, neurotransmitters, neurogenesis, and synaptic function. Front Pharmacol. 2020;11(:1270):1\u201314.","journal-title":"Front Pharmacol"},{"issue":"6","key":"691_CR24","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.3390\/molecules27061816","volume":"27","author":"ZR Chen","year":"2022","unstructured":"Chen ZR, Huang JB, Yang SL, Hong FF. Role of cholinergic signaling in Alzheimer\u2019s disease. Molecules. 2022;27(6):1816\u201338.","journal-title":"Molecules"},{"issue":"3","key":"691_CR25","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1096\/fj.10-168492","volume":"25","author":"S D\u2019Aniello","year":"2011","unstructured":"D\u2019Aniello S, Somorjai I, Garcia-Fernandez J, Topo E, D\u2019Aniello A. D-Aspartic acid is a novel endogenous neurotransmitter. FASEB J. 2011;25(3):1014\u201327.","journal-title":"FASEB J"},{"issue":"2:331","key":"691_CR26","first-page":"1","volume":"11","author":"A Arafah","year":"2023","unstructured":"Arafah A, Khatoon S, Rasool I, Khan A, Rather MA, Abujabal KA, et al. The future of precision medicine in the cure of Alzheimer\u2019s disease. Biomedicines. 2023;11(2:331):1\u201321.","journal-title":"Biomedicines"},{"issue":"9","key":"691_CR27","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/j.cell.2023.02.035","volume":"186","author":"K Baek","year":"2023","unstructured":"Baek K, Scott DC, Henneberg LT, King MT, Mann M, Schulman BA. Systemwide disassembly and assembly of SCF ubiquitin ligase complexes. Cell. 2023;186(9):1895\u2013911.","journal-title":"Cell"},{"key":"691_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gene.2022.146972","volume":"851","author":"YL Zhong","year":"2023","unstructured":"Zhong YL, Li JY, Ye M, Jin XF. The characteristics of FBXO7 and its role in human diseases. Gene. 2023;851:1\u201314.","journal-title":"Gene"},{"issue":"10","key":"691_CR29","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1038\/s41593-018-0235-9","volume":"21","author":"C Soto","year":"2018","unstructured":"Soto C, Pritzkow S. Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases. Nat Neurosci. 2018;21(10):1332\u201340.","journal-title":"Nat Neurosci"},{"issue":"11","key":"691_CR30","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.tins.2007.08.005","volume":"30","author":"AN Hegde","year":"2007","unstructured":"Hegde AN, Upadhya SC. The ubiquitin-proteasome pathway in health and disease of the nervous system. Trends Neurosci. 2007;30(11):587\u201395.","journal-title":"Trends Neurosci"},{"issue":"10","key":"691_CR31","doi-asserted-by":"publisher","first-page":"3352","DOI":"10.1523\/JNEUROSCI.5659-11.2012","volume":"32","author":"T Watanabe","year":"2012","unstructured":"Watanabe T, Hikichi Y, Willuweit A, Shintani Y, Horiguchi T. FBL2 regulates amyloid precursor protein (APP) metabolism by promoting ubiquitination-dependent APP degradation and inhibition of APP endocytosis. J Neurosci. 2012;32(10):3352\u201365.","journal-title":"J Neurosci"},{"issue":"5","key":"691_CR32","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.molcel.2018.01.038","volume":"69","author":"X Liu","year":"2018","unstructured":"Liu X, Reitsma JM, Mamrosh JL, Zhang Y, Straube R, Deshaies RJ. Cand1-mediated adaptive exchange mechanism enables variation in F-box protein expression. Mol Cell. 2018;69(5):773\u201386. e6.","journal-title":"Mol Cell"},{"issue":"11","key":"691_CR33","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1089\/hum.2017.160","volume":"28","author":"F Piguet","year":"2017","unstructured":"Piguet F, Alves S, Cartier N. Clinical gene therapy for neurodegenerative diseases: past, present, and future. Hum Gene Ther. 2017;28(11):988\u20131003.","journal-title":"Hum Gene Ther"},{"issue":"7","key":"691_CR34","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1007\/s12015-022-10375-3","volume":"18","author":"AR Mercer-Smith","year":"2022","unstructured":"Mercer-Smith AR, Buckley A, Valdivia A, Jiang WL, Thang M, Bell N, et al. Next-generation tumor-homing induced neural stem cells as an adjuvant to radiation for the treatment of metastatic lung cancer. Stem Cell Rev Rep. 2022;18(7):2474\u201393.","journal-title":"Stem Cell Rev Rep"},{"issue":"8:1526","key":"691_CR35","first-page":"1","volume":"13","author":"V Poletti","year":"2021","unstructured":"Poletti V, Mavilio F. Designing lentiviral vectors for gene therapy of genetic diseases. Viruses. 2021;13(8:1526):1\u201314.","journal-title":"Viruses"}],"container-title":["Biomarker Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-024-00691-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40364-024-00691-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-024-00691-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:04:22Z","timestamp":1732147462000},"score":1,"resource":{"primary":{"URL":"https:\/\/biomarkerres.biomedcentral.com\/articles\/10.1186\/s40364-024-00691-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,21]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["691"],"URL":"https:\/\/doi.org\/10.1186\/s40364-024-00691-w","relation":{},"ISSN":["2050-7771"],"issn-type":[{"value":"2050-7771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,21]]},"assertion":[{"value":"26 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments with mice were approved by the Experimental Animal Ethics Committee of Southwest Medical University with reference number SWMU20220183.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"144"}}